Sign in

CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6462005278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
  1. S-8 Other Securities Offered to Employees in Benefit Plans
  2. 10-K/A Report 10-K/A
  3. 8-K Event Other events
  4. 10-K/A Report 10-K/A
  5. 10-K Report Annual Report
  6. 8-K Event Results of operations · Regulation FD disclosure
  7. 4 Insider Changes in Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 8-K Event Delisting notice · Executive or director change
  10. 8-K Event Other events
  11. SC 13G/A Stake Amended Statement of Ownership
  12. 8-K Event Material agreement
  13. 424B5 Offering Prospectus
  14. 8-K Event Material agreement · Other events
  15. 424B2 Offering Prospectus
  16. POS EX Other Post-effective Amendment
  17. POS EX Other Post-effective Amendment
  18. POS EX Other Post-effective Amendment
  19. POS EX Other Post-effective Amendment
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 34 of 64 · 1,276 filings